The Dichotomous Responses Driven by β-Defensins
Open Access
- 12 June 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 1176
- https://doi.org/10.3389/fimmu.2020.01176
Abstract
Defensins are short, rapidly evolving, cationic antimicrobial host defence peptides with a repertoire of functions, still incompletely realised, that extends beyond direct microbial killing. They are released or secreted at epithelial surfaces, and in some cases, from immune cells in response to infection and inflammation. Defensins have been described as endogenous alarmins, alerting the body to danger and responding to inflammatory signals by promoting both local innate and adaptive systemic immune responses. However, there is now increasing evidence that they exert variable control on the response to danger; creating a dichotomous response that can suppress inflammation in some circumstances but exacerbate the response to danger and damage in others and, at higher levels, lead to a cytotoxic effect. Focussing in this review on human β-defensins, we discuss the evidence for their functions as proinflammatory, immune activators amplifying the response to infection or damage signals and/or as mediators of resolution of damage, contributing to a return to homeostasis. Finally, we consider their involvement in the development of autoimmune diseases.Funding Information
- Medical Research Council
- British Skin Foundation
This publication has 136 references indexed in Scilit:
- Human β‐defensin 3 affects the activity of pro‐inflammatory pathways associated with MyD88 and TRIFEuropean Journal of Immunology, 2011
- A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East AsiaHuman Mutation, 2011
- Carriers of Rare Missense Variants in IFIH1 Are Protected from PsoriasisJournal of Investigative Dermatology, 2010
- Human β‐defensin 3 has immunosuppressive activity in vitro and in vivoEuropean Journal of Immunology, 2010
- Defensin‐related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6European Journal of Immunology, 2009
- Allelic recombination between distinct genomic locations generates copy number diversity in human β-defensinsProceedings of the National Academy of Sciences of the United States of America, 2009
- Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3Journal of Allergy and Clinical Immunology, 2008
- Psoriasis is associated with increased β-defensin genomic copy numberNature Genetics, 2007
- Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2Proceedings of the National Academy of Sciences of the United States of America, 2007
- A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the ColonAmerican Journal of Human Genetics, 2006